If you are looking to buy weight loss pens Leeds or are considering the newly available oral tablet alternative, the choice between semaglutide injections and pills is no longer theoretical. In June 2026, the MHRA approved the UK’s first oral GLP-1 tablet for weight management. This guide breaks down everything you need to know about both options—dosage schedules, side-effect management, and how to access private prescriptions across London, Manchester, Birmingham, Leeds, and Glasgow.
The emergence of the once-daily oral tablet offers a clear alternative for those who struggle with needle anxiety or prefer to avoid the logistics of weekly injections. However, the dosing and administration requirements differ significantly. Here is what you need to understand about the Wegovy injection vs. tablet options.
Semaglutide Injection vs Oral Tablet: Comparison Overview
Both the injection and the tablet contain the same active ingredient, semaglutide, and produce broadly comparable weight loss results. The injectable form is taken once a week, while the tablet is taken once daily on an empty stomach .
The efficacy results from clinical trials show a similar weight loss profile. In the STEP 1 trial, the 2.4mg weekly injection produced average weight loss of 14.9% over 68 weeks, while in the OASIS 4 trial, the 25mg oral tablet produced average weight loss of 13.6% over 64 weeks.
How Does the Oral Tablet Work?
The oral semaglutide tablet contains the same active ingredient as the Wegovy injection but requires a much higher dose due to lower absorption. When swallowed, stomach acid breaks down most of the drug before it can cross the stomach lining .
To overcome this, the tablet uses an absorption enhancer called SNAC (salcaprozate sodium), which temporarily neutralizes acid around the tablet. This allows a small fraction of semaglutide to cross the stomach lining. Despite this, only approximately 1% of the oral dose survives digestion, compared to approximately 89% absorption via injection. This is why the oral maintenance dose is 25 mg daily versus 2.4 mg weekly by injection.
Approved Dosing Schedules
Wegovy Injection Dosing Schedule
The injection follows a 16-week dose escalation protocol:
- Weeks 1-4: 0.25 mg weekly
- Weeks 5-8: 0.5 mg weekly
- Weeks 9-12: 1.0 mg weekly
- Weeks 13-16: 1.7 mg weekly
- From Week 17: 2.4 mg weekly (maintenance dose)
For patients with obesity only (BMI of 30 or above), a higher 7.2 mg weekly dose has been approved by the MHRA since January 2026 .
Wegovy Oral Tablet Dosing Schedule
The MHRA-approved oral tablet schedule follows a four-step escalation:
- Step 1: 1.5 mg once daily (minimum 1 month)
- Step 2: 4 mg once daily (minimum 1 month)
- Step 3: 9 mg once daily (minimum 1 month)
- Step 4 (maintenance): 25 mg once daily
Patients currently on the 2.4 mg injection can transition directly to the 25 mg oral tablet once daily.
How to Take the Oral Tablet Correctly
The effectiveness of the tablet depends entirely on following a specific routine:
- Take first thing in the morning after an overnight fast of at least 8 hours
- Swallow whole with no more than 120ml (4oz) plain water—more water dilutes the absorption enhancer
- Do not crush, split, or chew the tablet
- Wait at least 30 minutes before eating, drinking, or taking other oral medications.
If a dose is missed, skip it—do not double up.
Side Effects Comparison
Both forms commonly cause nausea, vomiting, diarrhea, constipation, and stomach discomfort, particularly during the dose escalation phase. Overall rates of gastrointestinal side effects are broadly similar between the two, though vomiting appears somewhat more common with the daily 25 mg oral tablet.
In the OASIS-4 trial, 74% of participants experienced gastrointestinal side effects, compared with 42% on placebo. Nausea was reported in around 47% of participants and vomiting in around 31%. These figures are comparable to the injection’s reported rates of approximately 44% for nausea and 25% for vomiting.
Serious side effects are rare with both forms but include gallbladder problems and pancreatitis. Patients should stay hydrated by drinking 2–3 litres of water daily, particularly during the initial dose escalation phase.
📞 Ready to Start Your Weight Loss Journey?
Need help deciding between the injection and the tablet? Our team can guide you through the private prescription process across London, Manchester, Birmingham, Leeds, and Glasgow.
Eligibility Criteria
Both forms are approved for:
- Adults with a BMI of 30 or above, or
- Overweight adults (BMI 27–29.9) with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnoea
UK Access and Pricing
The oral tablet launched in the UK through regulated private providers in July 2026. NHS access is subject to ongoing NICE review.
Private injection costs vary significantly by dose and provider:
- Wegovy (semaglutide 2.4mg) costs approximately £175 to £295 per month at maintenance dose
- Wegovy 2.4mg monthly pens range from £220 to £295 depending on the provider
Oral tablet prices are likely to be similar to the injectable form, though higher doses (9mg and 25mg) are expected to be available in the coming weeks after the initial 1.5mg and 4mg doses.
Practical Considerations
Injection
- Once-weekly dosing may be easier to remember
- No strict fasting or waiting requirements
- Can be taken with or without food
- Requires refrigeration
- Avoids needle anxiety
Oral Tablet
- No needles or sharps bins
- No refrigeration required for storage
- Simpler for travel
- Requires strict daily routine (empty stomach, 30-minute wait)
- Lower absorption rate requires a much higher dose
The best option is the one you are most likely to stick to consistently. Both forms contain the same active ingredient and produce comparable weight loss results over 64–68 weeks. For patients in London, Manchester, Birmingham, Leeds, or Glasgow, private prescriptions are now available through regulated providers for both formulations.